stockrowCabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024.
- Revenue
- +12.2%
- EPS
- +79.4%
- Free cash flow
- −51.7%
- Total debt
- +10.8%
Quarter to September 2026, against a year earlier
Follow CBT
Alert me
Cabot Corporation (CBT) Total debt
Cabot Corporation's total debt at the end of fiscal 2025 was $1.1B, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $1.3B. Over the past ten years it has ranged from $915.0M (fiscal 2016) to $1.4B (fiscal 2022); the current reading is higher than 64% of that period. Cabot Corporation ranks 23rd of 60 Specialty Chemicals companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $1.1B | (0.88%) |
| FY2024 | $1.1B | (10.66%) |
| FY2023 | $1.3B | (11.57%) |
| FY2022 | $1.4B | 24.18% |
| FY2021 | $1.2B | 4.22% |
| FY2020 | $1.1B | 4.79% |
| FY2019 | $1.1B | 6.08% |
| FY2018 | $1.0B | 8.55% |
| FY2017 | $924.0M | 0.98% |
| FY2016 | $915.0M | (5.77%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $1.3B | (1.65%) |
| Jun 2026 | $1.3B | (2.00%) |
| Mar 2026 | $1.3B | 15.36% |
| Dec 2025 | $1.1B | (0.35%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| CLMT Calumet, Inc. compare | $2.7B |
| FUL H. B. Fuller Company compare | $2.1B |
| AVNT Avient Corporation compare | $1.8B |
| ASH Ashland Inc. compare | $1.4B |
| CBT Cabot Corporation | $1.3B |
| PRM Perimeter Solutions, SA compare | $1.2B |
| SXT Sensient Technologies Corporation compare | $790.4M |
| HWKN Hawkins, Inc. compare | $229.0M |
| WDFC WD-40 Company compare | $86.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on CBT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement